Company intelligence / Profile preview

Axsendo Clinical Research

Houston, Texas, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Axsendo Clinical Research operates as a multisite network CRO established in 2024, offering integrated trial sites, experienced principal investigators, and access to large, diverse patient populations—especially those underrepresented in medical research. Its sites provide diagnostics, labs, and imaging, and the company is rapidly expanding to multiple U.S. regions. The group is not a drug/product developer but supports development for sponsors.

Therapeutic areas: NephrologyCardiovascularEndocrinologyPulmonologyInfectious DiseasesNeurologyDermatologyPsychiatry
Modalities: Small moleculeBiologicDeviceVaccineProtein
Industry: Contract Research Organization

Partnerships

Peak Heart & Vascular (Arizona cardiovascular practice)

Beyond the preview

Go deeper on Axsendo Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axsendo Clinical Research.

Explore the full profile